Thanai Pongdee, MD - From Diagnosis to Treatment Escalation: Improving Outcomes Across the Patient Journey in Indolent Systemic Mastocytosis

Visit https://www.peervoice.com/FPN860 to view the entire programme with slides. After completing “Thanai Pongdee, MD - From Diagnosis to Treatment Escalation: Improving Outcomes Across the Patient Journey in Indolent Systemic Mastocytosis”, participants will be able to: Differentiate symptoms of indolent systemic mastocytosis (ISM) from other conditions with cutaneous manifestations; Implement evidence-based practices in the initial diagnosis and management of ISM; Utilize recommended clinical tools for the evaluation of symptoms and quality of life (QoL) in patients with ISM; and Identify patients with ISM who would benefit from escalation from symptomatic-directed therapies to disease-modifying therapies (such as selective KIT inhibitors).